- 2.4CiteScore
- 42 daysTime to First Decision
Endocrines, Volume 2, Issue 4
December 2021 - 14 articles
Cover Story: Telemedicine has been widely used by patients with type 1 diabetes (T1D) during the pandemic. Survey respondents from across the U.S. report that their adoption of telemedicine was driven by providers limiting in-person care, health concerns, public policies discouraging in-person contact, and changes in insurance and provider policies, which made telehealth newly accessible. The majority of patients utilizing telemedicine for T1D feel that it is effective, and hope to continue using it in the future. However, certain demographic groups report fewer perceived benefits from telemedicine, suggesting that it may be a less patient-centered care modality for some individuals with T1D. View this paper.
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Endocrines - ISSN 2673-396X